Patent · US Active

E. coli FimH mutants and uses thereof

US12357681B2 · kind B2 · utility

0Cited by
28References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 2021
Grant dateJul 15, 2025
Priority date
Expiry dateDec 17, 2041

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This disclosure relates to the design of E. coli mutated FimH polypeptides that result in improved biochemical properties and immunogenicity, compositions comprising such polypeptides, and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.